welcome to cyprotexcloe® screencloe® selectcloe® predict

Cloe® Screen

In vitro ADME screening service

Our in vitro ADME screening service offers a portfolio of assays for investigating: in vitro metabolism, in vitro permeability, solubility & physicochemical properties, protein binding and toxicity. Cloe® Screen delivers consistent, accurate compound data with cost-efficiency that comes from a highly automated approach.

  • Highly reproducible, accurate data - validated and used by over 200 Pharmaceutical and Biotechnology companies.
  • Delivery of data for core in vitro ADME screening and physicochemical assays is within 10 working days to fit in with the make-test timelines in drug discovery.
  • Highly cost effective due to our emphasis on high throughput engineering.
  • Attention to good quality customer care, with highly trained Principal Scientists on hand to explain results and suggest the most appropriate experimental strategy.

Cloe® Screen has passed evaluations by both large pharmaceutical and smaller biotechnology partners who now routinely use Cloe® Screen to support their drug discovery. 

Cloe® Screen Services

In vitro metabolism
cytochrome P450 inhibition
cytochrome P450 time dependent inhibition
cytochrome P450 reaction phenotyping
microsomal stability
S9 stability
hepatocyte stability
plasma stability
microsomal binding
In vitro permeability
PAMPA
Caco-2 permeability
MDCK (wild type) permeability
MDR1-MDCK permeability
Physicochemical properties
turbidimetric solubility
thermodynamic solubility
CHI
log D
chemical stability
Protein binding
plasma protein binding
Toxicity
hERG channel inhibition (IC50 determination)

Additional services are available - see Cloe® Select

Can't see the assay you need?

Please contact our Product Development Team with your requirements.

request

Request a quotation or
one of our publications.

Quotation   Catalogue
ADME guide
contact

Contact us for more information on Cyprotex, including our extensive range of ADME/PK services
and pricing.

contact
careerscontactlegalprivacy
This website was last updated
on 29th July 2010
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.